In this microlearning module, an expert faculty provides an overview of the considerations for management of CKD associated with T2D, with a focus on pharmacotherapy options.
A leading expert provides an overview of the considerations for management of CKD associated with T2D, with a focus on pharmacotherapy options.
Dr Vivian Fonseca provides insights on how to tailor the management of type 2 diabetes (T2D) and chronic kidney disease (CKD) for your individual patients, including treatment recommendations for high-risk patients and those with concurrent cardiovascular disease.
You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.